Autopsy report · NCT03979820

A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood Pressure

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Study discontinued - testing of highest dose obsolete”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months before it started.
Ran for about 8 months before it stopped.
53 participants enrolled.
Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Boehringer Ingelheim
Sponsor type: Industry
Conditions: Healthy
Interventions: BI 1467335; Placebo; Phenelzine sulfate; Tyramine
Participants: 53
Sites: 1
Countries: Netherlands

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.